Hold at benchmark weight or slightly below; add on $155-158 pullback only; preemptive trim on $159.82 close with volume or hawkish FOMC surprise
HOLD at benchmark weight or slightly below ($162 zone) with trailing stop to $159.82. The Q3 print is genuine (710 bps gross margin expansion, raised FY26 EPS to $6.55, $3.7B TTM FCF, 67-year dividend streak, accelerating buybacks $356M vs $20M baseline), HON divergence signals real institutional flow, and DeltaV/Nigel AI/Ovation AI Agents productization is real installed-base monetization. However, paying 35.46x TTM P/E at 97% of 52-week high with $27.65B goodwill (30% of market cap), $11.57B net debt (tripled), MACD at March-correction precursory level, and 48% Fed hike probability makes aggressive entry wrong. The neutral analyst's $155-158 VWMA zone (3-4% pullback) provides calibrated margin without requiring technical breakdown. Simplify from four triggers to binary posture: hold core, add on pullback, trim on confirmed $159.82 break with volume or hawkish FOMC, reassess at Q4 FY26 print. Price target anchored at midpoint $163-167 (not bull case $175) per symmetric outcome guidance; upside $175 requires both execution AND multiple expansion vs downside $140-145 requiring recession, EPS revisions, or sector contagion.
| Position | Action |
|---|---|
| Current levels ($160+) | Do NOT initiate new longs; maintain benchmark weight or slightly below |
| Pullback to $155-158 (VWMA zone, 3-4% pullback) | Stage incremental adds for meaningful margin of safety |
| Aggressive add at $159-160 | REJECT — insufficient 1.5% margin |
| Conservative add at $146-148 | REJECT — requires technical damage that signals thesis deterioration |
| Hawkish FOMC surprise September 16 OR close below $159.82 on volume with MACD rolling over | Reduce exposure by 25-50% preemptively |
EMR is a transformed software-tilted, AI-leveraged industrial compound engine with 710 bps gross margin expansion, 26.92% operating margins, and the DeltaV data center launch positioning it directly into the AI capex supercycle.
| Indicator | Value | Signal |
|---|---|---|
| Close | 162.05 | bullish |
| 10 EMA | 159.82 | bullish |
| 50 SMA | 146.03 | bullish |
| 200 SMA | 140.11 | bullish |
| RSI | 65.40 | bullish |
| MACD | 5.68 | bullish |
| MACD Signal | 4.94 | bullish |
| MACD Histogram | 0.74 | bullish |
| Bollinger Upper Band | 170.28 | neutral |
| ATR | 4.44 | neutral |
| VWMA | 156.69 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above $170 on volume greater than 3M AND forward EPS revisions moving toward $7.50+
Then: Upgrade to Overweight
EV: Targets: $166 (52-week high) → $170 (Bollinger upper band); 200 SMA at $140.11 acts as structural floor · concedes: Valuation discipline is real; 79.2% three-year return means easy money may be made; Macro headwinds (30Y at 19-year high, 48% chance of 2026 hike) are cross-sector headwinds, not EMR-specific; Leadership transition is a tail risk, though market has priced it as continuity; MACD at 5.68 approaching prior peaks (Feb 2026 peaked at 6-7); Volume at 1.7M during consolidation is normal but shows tape deterioration on single sessions
EMR is a good company at a bad price in a bad macro—the stock has already fully discounted the operational improvements, leaving no margin of safety for the balance sheet stress, goodwill bomb, leadership transition, and macro headwinds converging simultaneously.
· concedes: EMR has genuinely improved margins (45.7% to 52.8%); EMR has genuinely raised guidance; EMR has genuinely launched a relevant product (DeltaV for data centers); The business quality is real; Forward P/E of 22.4x is reasonable for a stable grower (though not for an industrial at a cyclical inflection)
→ vs conservative: TTM P/E of 35.46x is meaningless for a company mid-transformation with 80%+ gross margin subscription revenue compounding—the bear case uses a rearview mirror while driving forward
→ vs conservative: Goodwill of $27.65B is a software acquisition accounting artifact, not operational risk; impairment only triggers on operational deterioration, and the opposite is happening with raised guidance
→ vs conservative: MACD at prior peak levels is technically true but practically misleading—prior peak preceded correction due to different cycle, different macro regime, different earnings trajectory
→ vs conservative: $146-148 reload zone has a habit of becoming $135 zone when macro tailwinds shift; waiting for pullback risks broken technical setup and decisive market rejection of breakout
→ vs conservative: HON divergence is the single most underweighted element—HON down 51.5% while EMR raises guidance creates structural bid from institutional buyers seeking industrial automation exposure without HON baggage
→ vs conservative: DeltaV data center automation is positioned in early innings of 5-7 year AI infrastructure supercycle; conservative 'priced in' framing ignores secular trend maturity level
→ vs conservative: EMR is a quality industrial compounder dependent on operating execution, not long-duration growth dependent on multiple expansion—30Y yields don't impair the $2.67B FCF stream
→ vs conservative: Leadership transition '3-5% de-rating rule of thumb' applies to companies without clear strategic direction; EMR's explicit AI-automation acceleration strategy makes this a batton-passing scenario
→ vs conservative: Opportunity cost of waiting is asymmetric—every day EMR trades at $159-165 with intact technicals is compounding exposure to next leg up; conservative 'do not initiate new buys' produces mediocre returns
| Volume | 1,702,488 | neutral |
Support: 159.82 · 156.69 · 146.03 · 140.11 | Resistance: 164.31 · 165.79 · 170.28
EMR is in a strong, confirmed uptrend with all three moving averages stacked bullishly (10 EMA 159.82 > 50 SMA 146.03 > 200 SMA 140.11). The stock printed an all-time-high of 164.31 on 2026-08-05 and is currently consolidating just below that level. RSI reset from 72.48 (overbought) to 65.40 (healthy), MACD crossed bullish on 2026-07-22 and is maturing at 5.68. ATR of 4.44 indicates elevated but compressing volatility. Recommendation: HOLD for existing positions with 10 EMA trailing stop; BUY on pullbacks to 159-160 zone with stops below 157.60 (1 ATR) to 153.17 (2 ATR). Watch for MACD bearish divergence if price makes new highs but momentum does not confirm.
Market Cap
$90.39B
P/E (TTM)
35.46x
Forward P/E
22.40x
PEG Ratio
1.88
Price to Book
4.44x
EPS (TTM)
$4.57
Forward EPS
$7.23
Dividend Yield
1.36%
Beta
1.235
52-Week High
$166.35
52-Week Low
$122.64
Book Value
$36.54
Revenue FY2025
$18,016M
Gross Profit FY2025
$9,519M
Gross Margin FY2025
52.8%
Operating Income FY2025
$3,532M
Operating Margin FY2025
19.6%
Net Income FY2025
$2,293M
Diluted EPS FY2025
$4.04
Total Assets FY2025
$41,964M
Goodwill & Intangibles FY2025
$27,651M
Total Debt FY2025
$13,759M
Net Debt FY2025
$11,572M
Stockholders' Equity FY2025
$20,282M
Cash & Equivalents FY2025
$1,544M
Current Ratio FY2025
0.90
Debt to Equity FY2025
67.7%
Working Capital FY2025
-$1,214M
Operating Cash Flow FY2025
$3,098M
Free Cash Flow FY2025
$2,667M
CapEx FY2025
$431M
Dividends Paid FY2025
$1,192M
Share Repurchases FY2025
$1,167M
Profit Margin (TTM)
13.83%
Operating Margin (TTM)
26.92%
Gross Margin (TTM)
53.2%
EBITDA (TTM)
$6.06B
EBITDA Margin (TTM)
32.5%
EBITDA FY2025
$4.84B
Return on Equity (TTM)
12.8%
Return on Assets (TTM)
6.9%
Net Debt/EBITDA
1.91x
Interest Expense FY2025
$387M
Tax Rate FY2025
23.7%
Strengths
Concerns
Emerson Electric has executed a successful transformation into an industrial automation and software pure-play, with revenue growing from $13.80B (FY2022) to $18.02B (FY2025) and gross margins expanding 710 basis points to 52.8% through the acquisition of AspenTech (~80%+ gross margins) and NI. The company demonstrates strong free cash flow generation of $2.67B with an industry-leading 26.92% operating margin, though the balance sheet shows elevated leverage with net debt of $11.57B and goodwill/intangibles of $27.65B representing 66% of assets. The valuation reflects the positive transformation narrative with a forward P/E of 22.4x pricing in substantial earnings growth, but the TTM P/E of 35.5x and negative tangible book value limit margin of safety if execution on the AspenTech integration disappoints.
Macro: The macro backdrop is the most hostile for quality industrials in 2026. The 30-year Treasury yield touched a 19-year high (highest since 2007), with the 10-year also elevated, creating a rising discount-rate headwind for long-duration quality names. Fed policy has decisively repriced hawkish: Polymarket shows 85% probability of no cuts in 2026, 70% for a hold at the September 2026 meeting, and 48% for a rate hike this year — roughly a coin flip. Oil is bid on geopolitical risk (Trump's threats to bomb Oman), pressuring margins for cyclicals. U.S. shale majors are cutting spending despite higher oil prices, signaling soft upstream capex demand. Broad equity risk-off is underway with S&P 500, Dow, and Nasdaq all lower mid-week. The only supportive element is low US recession probability (8%), but this does not offset the rising-rate and rising-energy headwind combination.